Bio

Dr. Chen is a Clinical Assistant Professor with the Division of Pediatric Pulmonary and Sleep Medicine. She grew up in the Bay Area and attended undergraduate school at UC Berkeley (Go Bears!). She ventured across the country received her graduate and medical degrees at Boston University School of Medicine. After experiencing cold and snowy winters of the east coast, she returned to the Bay Area where she completed her pediatric residency and pulmonology fellowship at UCSF Benioff Children's Hospital Oakland. She joined Bay Area Pediatric Pulmonary Medical Group and subsequently the Division of Pediatric Pulmonary Medicine at Stanford University in 2015. She then followed her husband and moved to Los Angeles in 2016 where she joined the Division of Pediatric Pulmonology at UCLA as Associate Director of the Cystic Fibrosis Center. A few years later, she decided to return to her roots in the Bay Area. She made her way back to Stanford University and rejoined the pediatric pulmonology group in November 2019. She enjoys caring for children, from infancy and beyond, with pulmonary diseases and developing relationships with their families. Her particular interests include bronchopulmonary dysplasia, asthma, neuromuscular disease, cystic fibrosis, and evaluation of complex airways with bronchoscopy. She also has interest in quality improvement and policy and procedure development.

Clinical Focus

  • Pediatric Pulmonology

Academic Appointments

Professional Education

  • Board Certification: American Board of Pediatrics, Pediatric Pulmonology (2016)
  • Fellowship: UCSF Benioff Childrens Hospital Pediatric Pulmonary Fellowship (2015) CA United States of America
  • Board Certification: American Board of Pediatrics, Pediatrics (2011)
  • Residency: UCSF Benioff Childrens Hospital Pediatric Residency (2011) CA
  • Medical Education: Boston University School of Medicine (2008) MA

Contact

  • Clinical (Primary)  Stanford Children's Health Specialty Services Sunnyvale 1195 W Fremont Ave Sunnyvale, CA 94087 (669) 233-2880 (fax)

Additional Clinical Info

All Publications

  • MODIFIED ASSESSMENT OF COMPETENCY IN THORACIC SONOGRAPHY (ACTS) SCALE IN THE NICU AND PICU Dasani, R., Bhargava, V., Chan, B., Hamilton, C., Seekins, J., Halabi, S., Chen, D., Reddy, C., Hilgenberg, S., Haileselassie, B., Bhombal, S. LIPPINCOTT WILLIAMS & WILKINS. 2023: 302

    View details for Web of Science ID 000921450900590

  • ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections. ATS scholar Gross, J. E., McCown, M. Y., Okorie, C. U., Bishay, L. C., Dy, F. J., Astudillo, C. L., Muhlebach, M. S., Abu-Nassar, S., Chen, D. Y., Hossain, N., Wang, R., Klouda, T., Martiniano, S. L., Lenhart-Pendergrass, P., Kirkby, S., Ortenberg, R., McSparron, J. I., Wang, T., Hayes, M. M., Coruh, B. 2021; 2 (3): 452-467

    Abstract

    The following is a concise review of the Pediatric Pulmonary Medicine Core reviewing pediatric pulmonary infections, diagnostic assays, and imaging techniques presented at the 2021 American Thoracic Society Core Curriculum. Molecular methods have revolutionized microbiology. We highlight the need to collect appropriate samples for detection of specific pathogens or for panels and understand the limitations of the assays. Considerable progress has been made in imaging modalities for detecting pediatric pulmonary infections. Specifically, lung ultrasound and lung magnetic resonance imaging are promising radiation-free diagnostic tools, with results comparable with their radiation-exposing counterparts, for the evaluation and management of pulmonary infections. Clinicians caring for children with pulmonary disease should ensure that patients at risk for nontuberculous mycobacteria disease are identified and receive appropriate nontuberculous mycobacteria screening, monitoring, and treatment. Children with coronavirus disease (COVID-19) typically present with mild symptoms, but some may develop severe disease. Treatment is mainly supportive care, and most patients make a full recovery. Anticipatory guidance and appropriate counseling from pediatricians on social distancing and diagnostic testing remain vital to curbing the pandemic. The pediatric immunocompromised patient is at risk for invasive and opportunistic pulmonary infections. Prompt recognition of predisposing risk factors, combined with knowledge of clinical characteristics of microbial pathogens, can assist in the diagnosis and treatment of specific bacterial, viral, or fungal diseases.

    View details for DOI 10.34197/ats-scholar.2021-0034RE

    View details for PubMedID 34667993

  • A pilot study of heated and humidified low flow oxygen therapy: An assessment in infants with mild and moderate bronchiolitis (HHOT AIR study) PEDIATRIC PULMONOLOGY Chen, D. Y., Zee, E. D., Gildengorin, G., Fong, E. W. 2019; 54 (5): 620–27

    View details for DOI 10.1002/ppul.24267

    View details for Web of Science ID 000468315500016